ÂÜÀòÂÒÂ×

Shangzhong Li is a Senior Scientist at Bristol Myers Squibb since June 2023, focusing on reverse translation through late-stage multi-omics clinical datasets. Previously, Shangzhong served as a Manager at Pfizer from April 2019 to June 2023, specializing in spatial transcriptomics data analysis for biomarker discovery and immuno-oncology target discovery utilizing multi-omics data integration. Shangzhong completed a Ph.D. in Bioengineering at UC San Diego from 2014 to 2019, where research concentrated on NGS data analysis for CHO cells, and also held a summer internship at Celgene in 2017, investigating drug targets in MYC-driven multiple myeloma patients. Educational background includes a Master's degree in Bioengineering from UC San Diego (2012-2014), and a Bachelor of Engineering in Bioengineering and Biomedical Engineering from Chongqing University (2008-2012).